{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:03:44Z","timestamp":1790960624190,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173018, 82370113"],"award-info":[{"award-number":["82173018, 82370113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Provincial and Ministerial Co-construction Project of Henan province","award":["SBGJ202102133\uff0cSBG202403034"],"award-info":[{"award-number":["SBGJ202102133\uff0cSBG202403034"]}]},{"name":"Young and Middle-aged Health Science and Technology Innovation Talents Project of Henan province","award":["YXKC2021036"],"award-info":[{"award-number":["YXKC2021036"]}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["QNCXTD2023005"],"award-info":[{"award-number":["QNCXTD2023005"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["232300421054, 232300421286"],"award-info":[{"award-number":["232300421054, 232300421286"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhengzhou University Education and Teaching Reform Research and Practice Project","award":["2022ZZUJG298"],"award-info":[{"award-number":["2022ZZUJG298"]}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242301420071"],"award-info":[{"award-number":["242301420071"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06241-8","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:53:04Z","timestamp":1740563584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14\/m6A\/SLC3A2 axis mediated cell ferroptosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Huanxiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3869-7153","authenticated-orcid":false,"given":"Junhu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"6241_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398:535\u201354.","journal-title":"Lancet"},{"key":"6241_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"6241_CR3","doi-asserted-by":"publisher","first-page":"122652","DOI":"10.1016\/j.lfs.2024.122652","volume":"346","author":"MJ Sanaei","year":"2024","unstructured":"Sanaei MJ, Pourbagheri-Sigaroodi A, Rezvani A, Zaboli E, Salari S, Masjedi MR, Bashash D. Lung cancer vaccination from concept to reality: a critical review of clinical trials and latest advances. Life Sci. 2024;346:122652.","journal-title":"Life Sci"},{"key":"6241_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/COC.0000000000001088","volume":"47","author":"J Xu","year":"2024","unstructured":"Xu J, Tian L, Qi W, Lv Q, Wang T. Advancements in NSCLC: from pathophysiological insights to targeted treatments. Am J Clin Oncol. 2024;47:291\u2013303.","journal-title":"Am J Clin Oncol"},{"key":"6241_CR5","doi-asserted-by":"publisher","first-page":"105583","DOI":"10.1016\/j.phrs.2021.105583","volume":"167","author":"RF Dong","year":"2021","unstructured":"Dong RF, Zhu ML, Liu MM, Xu YT, Yuan LL, Bian J, Xia YZ, Kong LY. EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: from molecular mechanisms to clinical research. Pharmacol Res. 2021;167:105583.","journal-title":"Pharmacol Res"},{"key":"6241_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.resinv.2024.01.011","volume":"62","author":"H Kagamu","year":"2024","unstructured":"Kagamu H. Immunotherapy for non-small cell lung cancer. Respir Investig. 2024;62:307\u201312.","journal-title":"Respir Investig"},{"key":"6241_CR7","doi-asserted-by":"publisher","first-page":"216569","DOI":"10.1016\/j.canlet.2023.216569","volume":"582","author":"Y Yang","year":"2024","unstructured":"Yang Y, Wang J, Wang J, Zhao X, Zhang T, Yang Y, Pang J, Ou Q, Wu L, Xu X, et al. Unrevealing the therapeutic benefits of radiotherapy and consolidation immunotherapy using ctDNA-defined tumor clonality in unresectable locally advanced non-small cell lung cancer. Cancer Lett. 2024;582:216569.","journal-title":"Cancer Lett"},{"key":"6241_CR8","doi-asserted-by":"publisher","first-page":"e32899","DOI":"10.1097\/MD.0000000000032899","volume":"102","author":"Y Alduais","year":"2023","unstructured":"Alduais Y, Zhang H, Fan F, Chen J, Chen B. Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment. Med (Baltim). 2023;102:e32899.","journal-title":"Med (Baltim)"},{"key":"6241_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13046-024-03026-7","volume":"43","author":"F Ren","year":"2024","unstructured":"Ren F, Fei Q, Qiu K, Zhang Y, Zhang H, Sun L. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation. J Exp Clin Cancer Res. 2024;43:96.","journal-title":"J Exp Clin Cancer Res"},{"key":"6241_CR10","doi-asserted-by":"publisher","first-page":"859893","DOI":"10.3389\/fimmu.2022.859893","volume":"13","author":"K Wang","year":"2022","unstructured":"Wang K, Yang C, Li H, Liu X, Zheng M, Xuan Z, Mei Z, Wang H. Role of the epigenetic modifier JMJD6 in Tumor Development and Regulation of Immune Response. Front Immunol. 2022;13:859893.","journal-title":"Front Immunol"},{"key":"6241_CR11","doi-asserted-by":"publisher","first-page":"e2201483119","DOI":"10.1073\/pnas.2201483119","volume":"119","author":"ME Cockman","year":"2022","unstructured":"Cockman ME, Sugimoto Y, Pegg HB, Masson N, Salah E, Tumber A, Flynn HR, Kirkpatrick JM, Schofield CJ, Ratcliffe PJ. Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6. Proc Natl Acad Sci U S A. 2022;119:e2201483119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6241_CR12","doi-asserted-by":"publisher","first-page":"e12747","DOI":"10.1111\/cpr.12747","volume":"53","author":"J Yang","year":"2020","unstructured":"Yang J, Chen S, Yang Y, Ma X, Shao B, Yang S, Wei Y, Wei X. Jumonji domain-containing protein 6 protein and its role in cancer. Cell Prolif. 2020;53:e12747.","journal-title":"Cell Prolif"},{"key":"6241_CR13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/1541-7786.MCR-22-0370","volume":"21","author":"B Cioni","year":"2023","unstructured":"Cioni B, Ratti S, Piva A, Tripodi I, Milani M, Menichetti F, Langella T, Botti L, De Cecco L, Chiodoni C, et al. JMJD6 shapes a Pro-tumor Microenvironment via ANXA1-Dependent macrophage polarization in breast Cancer. Mol Cancer Res. 2023;21:614\u201327.","journal-title":"Mol Cancer Res"},{"key":"6241_CR14","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.molcel.2022.06.003","volume":"82","author":"J Zhou","year":"2022","unstructured":"Zhou J, Simon JM, Liao C, Zhang C, Hu L, Zurlo G, Liu X, Fan C, Hepperla A, Jia L, et al. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. Mol Cell. 2022;82:3030\u2013e30443038.","journal-title":"Mol Cell"},{"key":"6241_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1038\/s41388-023-02781-9","volume":"42","author":"S Chen","year":"2023","unstructured":"Chen S, Wang M, Lu T, Liu Y, Hong W, He X, Cheng Y, Liu J, Wei Y, Wei X. JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3\/IL-10 axis. Oncogene. 2023;42:2737\u201350.","journal-title":"Oncogene"},{"key":"6241_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:88.","journal-title":"Cell Death Dis"},{"key":"6241_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D Fotiadis","year":"2013","unstructured":"Fotiadis D, Kanai Y, Palacin M. The SLC3 and SLC7 families of amino acid transporters. Mol Aspects Med. 2013;34:139\u201358.","journal-title":"Mol Aspects Med"},{"key":"6241_CR18","doi-asserted-by":"publisher","first-page":"127976","DOI":"10.1016\/j.ijbiomac.2023.127976","volume":"254","author":"HH Wang","year":"2024","unstructured":"Wang HH, Fan SQ, Zhan YT, Peng SP, Wang WY. Suppression of the SLC7A11\/glutathione axis causes ferroptosis and apoptosis and alters the mitogen-activated protein kinase pathway in nasopharyngeal carcinoma. Int J Biol Macromol. 2024;254:127976.","journal-title":"Int J Biol Macromol"},{"key":"6241_CR19","doi-asserted-by":"publisher","first-page":"e1904197","DOI":"10.1002\/adma.201904197","volume":"31","author":"C Liang","year":"2019","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019;31:e1904197.","journal-title":"Adv Mater"},{"key":"6241_CR20","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s10637-021-01070-0","volume":"39","author":"MR Liu","year":"2021","unstructured":"Liu MR, Zhu WT, Pei DS. System Xc(-): a key regulatory target of ferroptosis in cancer. Invest New Drugs. 2021;39:1123\u201331.","journal-title":"Invest New Drugs"},{"key":"6241_CR21","first-page":"12","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, Gan B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018;38:12.","journal-title":"Cancer Commun (Lond)"},{"key":"6241_CR22","doi-asserted-by":"crossref","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C. Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci. 2022;24(1):449.","DOI":"10.3390\/ijms24010449"},{"key":"6241_CR23","doi-asserted-by":"publisher","first-page":"106793","DOI":"10.1016\/j.jbc.2024.106793","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang Z, Zhang C, Zhang L, Chen H, Xiao N, Bai L, Liu H, Wan J. 5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer. J Biol Chem. 2024;300:106793.","journal-title":"J Biol Chem"},{"key":"6241_CR24","doi-asserted-by":"crossref","unstructured":"Zhang W, Sun Y, Bai L, Zhi L, Yang Y, Zhao Q, et al. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. J Clin Invest. 2021;131(22):e152067.","DOI":"10.1172\/JCI152067"},{"key":"6241_CR25","doi-asserted-by":"publisher","first-page":"216465","DOI":"10.1016\/j.canlet.2023.216465","volume":"579","author":"S Cai","year":"2023","unstructured":"Cai S, Zhang B, Huang C, Deng Y, Wang C, Yang Y, Xiang Z, Ni Y, Wang Z, Wang L, et al. CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT\/GPX4 pathway. Cancer Lett. 2023;579:216465.","journal-title":"Cancer Lett"},{"key":"6241_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12943-017-0744-2","volume":"16","author":"X Liu","year":"2017","unstructured":"Liu X, Si W, Liu X, He L, Ren J, Yang Z, Yang J, Li W, Liu S, Pei F, et al. JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component. Mol Cancer. 2017;16:175.","journal-title":"Mol Cancer"},{"key":"6241_CR27","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1002\/ijc.31816","volume":"144","author":"J Wan","year":"2019","unstructured":"Wan J, Liu H, Yang L, Ma L, Liu J, Ming L. JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4. Int J Cancer. 2019;144:2489\u2013500.","journal-title":"Int J Cancer"},{"key":"6241_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-019-0055-8","volume":"4","author":"H Zheng","year":"2019","unstructured":"Zheng H, Tie Y, Fang Z, Wu X, Yi T, Huang S, Liang X, Qian Y, Wang X, Pi R, et al. Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer. Signal Transduct Target Ther. 2019;4:24.","journal-title":"Signal Transduct Target Ther"},{"key":"6241_CR29","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1186\/s12967-023-04394-y","volume":"21","author":"R Pei","year":"2023","unstructured":"Pei R, Zhao L, Ding Y, Su Z, Li D, Zhu S, Xu L, Zhao W, Zhou W. JMJD6-BRD4 complex stimulates lncRNA HOTAIR transcription by binding to the promoter region of HOTAIR and induces radioresistance in liver cancer stem cells. J Transl Med. 2023;21:752.","journal-title":"J Transl Med"},{"key":"6241_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/00221309.1988.9711083","volume":"115","author":"AC Bentley","year":"1988","unstructured":"Bentley AC. A survey of celiac-sprue patients: effect of dietary restrictions on religious practices. J Gen Psychol. 1988;115:7\u201314.","journal-title":"J Gen Psychol"},{"key":"6241_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ, Shao ZM. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35:84\u2013e100108.","journal-title":"Cell Metab"},{"key":"6241_CR32","doi-asserted-by":"publisher","first-page":"e2203357","DOI":"10.1002\/advs.202203357","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Deng T, Zhang H, Zuo D, Zhu Q, Bai M, Liu R, Ning T, Zhang L, Yu Z, et al. Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes Chemoresistance in Colorectal Cancer. Adv Sci (Weinh). 2022;9:e2203357.","journal-title":"Adv Sci (Weinh)"},{"key":"6241_CR33","doi-asserted-by":"publisher","first-page":"101576","DOI":"10.1016\/j.tranon.2022.101576","volume":"27","author":"WM Huang","year":"2023","unstructured":"Huang WM, Li ZX, Wu YH, Shi ZL, Mi JL, Hu K, Wang RS. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis. Transl Oncol. 2023;27:101576.","journal-title":"Transl Oncol"},{"key":"6241_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13020-023-00820-x","volume":"18","author":"F Wang","year":"2023","unstructured":"Wang F, Sun Z, Zhang Q, Yang H, Yang G, Yang Q, Zhu Y, Wu W, Xu W, Wu X. Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer. Chin Med. 2023;18:122.","journal-title":"Chin Med"},{"key":"6241_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2741\/1802","volume":"11","author":"J Wysocka","year":"2006","unstructured":"Wysocka J, Allis CD, Coonrod S. Histone arginine methylation and its dynamic regulation. Front Biosci. 2006;11:344\u201355.","journal-title":"Front Biosci"},{"key":"6241_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.molcel.2010.11.024","volume":"40","author":"Y Yang","year":"2010","unstructured":"Yang Y, Lu Y, Espejo A, Wu J, Xu W, Liang S, Bedford MT. TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell. 2010;40:1016\u201323.","journal-title":"Mol Cell"},{"key":"6241_CR37","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ, et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. N Engl J Med. 2022;386:1973\u201385.","journal-title":"N Engl J Med"},{"key":"6241_CR38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nrc2947","volume":"10","author":"W Pao","year":"2010","unstructured":"Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760\u201374.","journal-title":"Nat Rev Cancer"},{"key":"6241_CR39","doi-asserted-by":"publisher","first-page":"e2200753119","DOI":"10.1073\/pnas.2200753119","volume":"119","author":"RQ Xiao","year":"2022","unstructured":"Xiao RQ, Ran T, Huang QX, Hu GS, Fan DM, Yi J, Liu W. A specific JMJD6 inhibitor potently suppresses multiple types of cancers both in vitro and in vivo. Proc Natl Acad Sci U S A. 2022;119:e2200753119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6241_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00438-015-1089-4","volume":"291","author":"Y Huang","year":"2016","unstructured":"Huang Y, Chen D, Liu C, Shen W, Ruan Y. Evolution and conservation of JmjC domain proteins in the green lineage. Mol Genet Genomics. 2016;291:33\u201349.","journal-title":"Mol Genet Genomics"},{"key":"6241_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13148-016-0205-6","volume":"8","author":"O Aprelikova","year":"2016","unstructured":"Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis. Clin Epigenetics. 2016;8:38.","journal-title":"Clin Epigenetics"},{"key":"6241_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/jnen\/nlab124","volume":"81","author":"AM Rosager","year":"2022","unstructured":"Rosager AM, Dahlrot RH, Sorensen MD, Bangso JA, Hansen S, Kristensen BW. The Epigenetic Regulator Jumonji Domain-Containing protein 6 (JMJD6) is highly expressed but not prognostic in IDH-Wildtype Glioblastoma patients. J Neuropathol Exp Neurol. 2022;81:54\u201360.","journal-title":"J Neuropathol Exp Neurol"},{"key":"6241_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12935-021-02010-x","volume":"21","author":"D Tong","year":"2021","unstructured":"Tong D. Correction to: the role of JMJD6\/U2AF65\/AR-V7 axis in castration-resistant prostate cancer progression. Cancer Cell Int. 2021;21:301.","journal-title":"Cancer Cell Int"},{"key":"6241_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2021.03.023","volume":"168","author":"L Ma","year":"2021","unstructured":"Ma L, Zhang X, Yu K, Xu X, Chen T, Shi Y, Wang Y, Qiu S, Guo S, Cui J, et al. Targeting SLC3A2 subunit of system X(C)(-) is essential for m(6)a reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Free Radic Biol Med. 2021;168:25\u201343.","journal-title":"Free Radic Biol Med"},{"key":"6241_CR45","doi-asserted-by":"publisher","first-page":"100503","DOI":"10.1016\/j.mtbio.2022.100503","volume":"17","author":"X Xu","year":"2022","unstructured":"Xu X, Cui J, Wang H, Ma L, Zhang X, Guo W, Xue X, Wang Y, Qiu S, Tian X, et al. IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Mater Today Bio. 2022;17:100503.","journal-title":"Mater Today Bio"},{"key":"6241_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol. 2019;20:156\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6241_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13046-022-02573-1","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen Q, He Y, Shi Q, Yin C, Xie Y, Yu H, Bao Y, Wang X, Tang C, Dong Z. STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2023;42:19.","journal-title":"J Exp Clin Cancer Res"},{"key":"6241_CR48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/mc.23585","volume":"62","author":"W Ge","year":"2023","unstructured":"Ge W, Gong Y, Li Y, Wu N, Ruan Y, Xu T, Shu Y, Qiu W, Wang Y, Zhao C. IL-17 induces non-small cell lung cancer metastasis via GCN5-dependent SOX4 acetylation enhancing MMP9 gene transcription and expression. Mol Carcinog. 2023;62:1399\u2013416.","journal-title":"Mol Carcinog"},{"key":"6241_CR49","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1093\/nar\/gkw808","volume":"44","author":"J Wan","year":"2016","unstructured":"Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y, Wang J, Zhu WG, Luo J, Zhang H. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res. 2016;44:10662\u201375.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06241-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06241-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:28:48Z","timestamp":1740565728000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06241-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6241"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06241-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed according to the ethical standards of the Declaration of Helsinki and received approval from the Ethics Committee at the First Affiliated Hospital of Zhengzhou University. Informed consent was obtained from all patients participating in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}